car t for autoimmune disease
27% Fewer Relapses: Chronic Disease Management Closes Autoimmune Door
Investigators presented data from 20 patients with multiple autoimmune diseases treated with allogeneic CAR-T at the ASH meeting, showing early signs of remission. A structured chronic disease management programme creates a shared baseline, integrates patient-reported outcomes and aligns specialty teams, which in turn readies patients for CAR-T and can lower